Lucid Diagnostics Inc (LUCD) Provides Business Update, Reports Prelim Q4

Go back to Lucid Diagnostics Inc (LUCD) Provides Business Update, Reports Prelim Q4

Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2023 Financial Results

March 25, 2024 5:30 PM EDT

Quarterly EsoGuard® revenue increased 33 percent sequentially

Expanding EsoGuard clinical validity and clinical utility data poised to drive medical policy coverage, including line of sight to Medicare coverage

Conference call and webcast to be held tomorrow, March 26th at 8:30 AM ET

NEW YORK, March 25, 2024 /PRNewswire/ -- ... More